STM-2457

N/A

Report date: 2024/11/12 13:56:22
NMEFirst In Class

Base Information

Drug NameSTM-2457
Drug Alias NameSTM-2457
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN6-adenosine-methyltransferase catalytic subunit inhibitors
TargetsN6-adenosine-methyltransferase catalytic subunit
Therapy Area/IndicationsLeukemia, Myeloid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CambridgeThe Wellcome Trust Sanger InstituteStorm Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesThe Wellcome Trust Sanger InstituteStorm Therapeutics LtdUniversity Of Cambridge
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A